Abstract: Natural bone consists of hard nanostructured hydroxyapatite (HA) in a nanostructured protein-based soft hydrogel template (ie, mostly collagen). For this reason, nanostructured HA has been an intriguing coating material on traditionally used titanium for improving orthopedic applications. In addition, helical rosette nanotubes (HRNs), newly developed materials which form through the self-assembly process of DNA base pair building blocks in body solutions, are soft nanotubes with a helical architecture that mimics natural collagen. Thus, the objective of this in vitro study was for the fi rst time to combine the promising attributes of HRNs and nanocrystalline HA on titanium and assess osteoblast (bone-forming cell) functions. Different sizes of nanocrystalline HA were synthesized in this study through a wet chemical precipitation process following either hydrothermal treatment or sintering. Transmission electron microscopy images showed that HRNs aligned with nanocrystalline HA, which indicates a high affi nity between both components. Some of the nanocrystalline HA formed dense coatings with HRNs on titanium. More importantly, results demonstrated enhanced osteoblast adhesion on the HRN/ nanocrystalline HA-coated titanium compared with conventional uncoated titanium. Among all the HRN/nanocrystalline HA coatings tested, osteoblast adhesion was the greatest when HA nanometer particle size was the smallest. In this manner, this study demonstrated for the fi rst time that biomimetic HRN/nanocrystalline HA coatings on titanium were cytocompatible for osteoblasts and, thus, should be further studied for improving orthopedic implants.
Introduction
Although conventionally synthesized biomaterials have been served well as orthopedic implants over the past half a century, high implant failure rates after 10-15 years of implantation necessitate improvement. For example, in the United States, nearly 11% of hip replacements and 8% of knee replacements were revision procedures of previously failed replacements in 2003 (AAOS 2003) . One of many reasons for implant failure is the incompatibility between osteoblasts (bone-forming cells) and today's implant materials such as titanium (Jayaraman et al 2004) . One approach to improve such implant materials is to design implants which are more similar to natural bone, and this is a role envisioned for nanotechnology. To date, nanomaterials (that is, materials with basic structural units, grains, particles, fi bers, or other constituent components in the range of 1-100 nm [Siegel and Fougere 1995] ) have exhibited enhanced cytocompatibility, mechanical, and electrical properties compared with respective conventional micronscale materials. The nanostructural features, favorable surface chemistry, and bioactive surfaces of nanomaterials which mimic bone signifi cantly promote selective protein (such as vitronectin, fi bronectin, etc) adsorption and effi ciently stimulate new bone formation compared with conventional materials, thus, possibly serving as the next generation of orthopedic implant materials (Zhang et al 2008a) .
One type of novel nanomaterial, helical rosette nanotubes (HRNs), are novel organic nanotubes that mimic the natural nanostructure of collagen and other components in bone. The DNA base pair building blocks of HRNs (the guaninecytosine motif) undergo self-assembly in body solutions to form a stable nanotube with a 3.5 nm outer diameter tube based on hydrogen bond formation, base-stacking interactions and hydrophobic effects (Figure 1 ) (Fenniri et al 2001) . Not only are HRNs biologically-inspired nanometric and helical architectures similar to collagen in bone, but they also can be functionalized with a diverse range of peptides (such as arginine-glycine-aspartic acid [RGD] and lysine) which have been known to enhance osteoblast functions. Previous studies have demonstrated the ability of HRNs to increase osteoblast adhesion as a coating material on titanium (Chun et al 2004 (Chun et al , 2005 .
Another major component in the bone matrix is hydroxyapatite (HA; Ca 10 (PO 4 ) 6 (OH) 2 ) which has been used as an orthopedic and dental implant material for decades (Hoexter 2002; Sammarco and Chang 2002) . HA is osteoconductive since its surface can undergo selective chemical reactivity with surrounding tissues, which results in a tight bond between bone and the implant. Moreover, studies have demonstrated that HA induced osteogenic differentiation of osteoblasts (Wang 2004) . Recently, studies have further improved HA for orthopedic applications by coating nanometer (instead of micron) HA crystals on titanium matching the crystal size of HA in bone. Nanophase HA has excellent cytocompatibility properties with osteoblasts (Chang et al 2006) and in vivo studies have demonstrated complete osseointegration of tantalum coated with nanophase HA after 2 weeks whereas tantalum coated with conventional (or micron) HA took up to 8 weeks (Sato 2006) . As a result, these promising properties of nanophase HA and HRNs have highlighted the possibility that collectively they should be studied for orthopedic applications.
Thus, the objective of this study was to determine material and cytocompatibility properties (with osteoblasts) of HRN/ HA composites. In this study, a wet chemistry precipitation method was used to synthesize HA (Lopez-Macipe et al 1998; Sato et al 2006) . This process, via a mild reaction under room temperature, is similar to the biomineralization process of bone and teeth. In addition, wet chemistry enabled good control of the crystalline phase and surface morphology of HA at the micrometer and nanometer levels (Duan and Wang 2006) . Moreover, since grain size is one of the important factors which may infl uence the growth of osteoblasts on implant materials, several grain sizes of nanocrystalline HA in HRNs were fabricated here by utilizing different sintering temperatures or hydrothermal treatment regimes. for 10 min at room temperature. Then, the solution with HA precipitates was treated hydrothermally at 200 °C for 20 h in a 125 ml Tefl on liner (Parr Instrument, Moline, IL) (Ioku and Yoshimura 1991) . This hydrothermal treatment method produced small grain sizes of nanocrystalline HA at relatively low temperatures but under a higher pressure (Sato et al 2005) . After 20 h, the nanocrystalline HA was centrifuged and rinsed sequentially with dH 2 O three times, then dried at 80 °C for 12 h. Larger grain sizes and higher yield rates of nano HA can be obtained without hydrothermal treatment. For this, 1 M calcium nitrate was slowly added to 0.6 M ammonium phosphate, while ethanol was used to disperse the mixture and ammonium hydroxide to adjust the pH up to 12. The mixture was then slightly heated at 40 °C for 1h and HA precipitated at room temperature for 24 h. The HA white powder was obtained after washing and centrifugation and was dried similar to the method described above. Then, the HA powder was sintered at 700 °C for 6 h to achieve a large nanocrystalline HA grain size or at 550 °C for 6 h to produce a middle nanocrystalline HA grain size.
Materials and methods

Synthesis of HA and preparation of HRNs
HRNs with lysine side chain (HRN-K1) building blocks were synthesized by using a general synthetic strategy (Fenniri et al 2001) . In total, six main intermediate products were synthesized in 16 steps of synthesis reactions to obtain HRN-K1 building blocks. Then, HRN-K1 building blocks were dissolved in dH 2 O to achieve a 0.1 mg/ml stock solution. 0.001 mg/ml HRN-K1 solution was prepared by diluting the stock solution with dH 2 O. Solutions were sterilized with a 0.22 μm syringe fi lter (Chun et al 2004) .
HRN and HA coatings on titanium
Titanium (Ti, 1 cm × 1 cm × 0.2 cm; SupraAlloys, Camarillo, CA) was cleaned according to standard procedures (Chun et al 2004) . 250 mg of each type of nano HA (specifi cally, small, middle and large HA grain sizes) was mixed with 5 ml 70% ethanol and sonicated for 20 min to obtain a homogenous HA solution. Then, 5 ml of 0.001 mg/ml HRN-K1 solution was added into each of the above mixtures. Nano HA and HRN-K1 were coated on the titanium surface by absorption for 45 minutes at room temperature and dried overnight. In addition, 0.001 mg/ml HRN-K1 without HA was coated on titanium. Uncoated titanium served as controls.
HRN and HA characterization
HRNs have been fully characterized as described elsewhere (Fenniri et al 2001; Chun et al 2004 Chun et al , 2005 . The nanocrystalline HA powders were characterized by X-ray diffraction (XRD; Siemens Diffraktometer D5000). Nanocrystalline HA, HRNs, and the combination of HRNs with nano HA were characterized with TEM (Philips, EM410 PW6008). The agglomerated mean particle size was determined by a particle size analyzer (Nano ZS, Malvern Instruments). The HRN/nanocrystalline HA coatings were characterized with SEM (LEO 1530-VP).
Osteoblast experiments
Osteoblast adhesion was determined on: (1) 0.001 mg/ml HRN-K1 with the small grain size nanocrystalline HA (prepared by the hydrothermal treatment) coated on titanium, (2) 0.001 mg/ml HRN-K1 with the middle grain size nano HA (prepared by sintering at 550 °C) coated on titanium, (3) 0.001 mg/ml HRN-K1 with the large grain size nanocrystalline HA (prepared by sintering at 700 °C) coated on titanium, (4) 0.001 mg/ml HRN-K1 alone coated on titanium, and (5) uncoated titanium. Human fetal osteoblasts (bone-forming cells, ATCC, CRL-11372, population numbers 8-10) were seeded at 3500 cells/cm 2 onto the above fi ve substrates and were cultured in Dulbecco's modifi ed eagle's medium (DMEM; Gibco/BRL, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT) and 1% penicillin/streptomycin (P/S; Hyclone) under standard cell culture conditions (37 °C, a humidifi ed, 5% CO 2 /95% air environment) for 4 h. After the prescribed time period, nonadherent cells were removed by washing with phosphate buffered saline (PBS). Adherent cells were then fi xed with 10% normal buffered formalin (NBF; Fisher Scientifi c), stained with 4',6-diamidino-2-phenylindole, dihydrochloride (DAPI; Invitrogen, Carlsbad, CA) and counted on fi ve random fi elds of view for each substrate using a Zeiss Axiovert 200M fl uorescence microscope.
Statistical analysis
Experiments were run in triplicate and repeated three separate times for each substrate. Data were represented by the mean value with the standard error of the mean (SEM) noted. A student's t-test was used to check statistical signifi cance between means and p Ͻ 0.1 was considered statistically signifi cant.
Results and discussion
Particle synthesis and the affi nity between HRN-K1 and HA In the present study, different grain sizes and morphologies of nanocrystalline HA were synthesized using two treatment methods. TEM images showed that HA precipitates did not have clear demarkation lines or regular shapes before hydrothermal treatments or sintering (Figure 2A ). Rod-like nanocrystalline HA particles were synthesized after hydrothermal treatment (~50-100 nm in length and 20-30 nm in width; Figure 2B ) and after sintering at 700 °C for 6 h (~100-170 nm in length and 20-30 nm in width; Figure 2D ). In addition, sintering HA powers at 550 °C for 6 h produced a middle grain size of irregular nanocrystallized HA with a more agglomerated morphology ( Figure 2C ). Most importantly, Figure 2E showed for the fi rst time a good affi nity between HRN-K1 and nanocrystalline HA. Specifi cally, a
Figure 2 TEM images of (A) HA precipitates before sintering, (B) small grain size nanocrystalline HA (prepared by hydrothermal treatment), (C) middle grain size nanocrystalline HA (prepared by sintering at 550 °C) with the inset at high magnifi cation, scale bar of the inset image is 20 nm, (D) large grain size nanocrystalline HA (prepared by sintering at 700 °C), (E) 0.01 mg/ml HRN-K1 with small grain size nanocrystalline HA (hydrothermal treatment nano HA served as a model); inset shows the enlarged region of (E) demonstrating the close HRN/HA interaction, and (F) 0.01 mg/ml HRN-K1 only. Arrows show the HRN-K1.
bundle of HRN-K1 attached and oriented on nanocrystalline HA surfaces by simple adsorption. Furthermore, by measuring the sizes of nanocrystalline HA in TEM images, Figure 3 provided quantifi ed results of the average HA grain sizes after hydrothermally treatment and sintering which demonstrated that hydrothermal treatment can yield much smaller crystallite sizes than other methods. Specifi cally, nanocrystalline HA prepared by the hydrothermal treatment had an average grain size of 82.84 nm (in length) while nanocrystalline HA particles prepared by sintering at either 550 °C or 700 °C had average grain sizes of 90.01nm and 129.81nm, respectively.
In addition, XRD provided evidence that crystalline HA was present in all particles (Figure 4) . Hydrothermally treated nanocrystalline HA displayed small amounts of peak broadening ( Figure 4A ), which supports the previously mentioned data of smaller crystallite sizes of hydrothermal nano HA compared with the other two types of sintered nano HA ( Figure 4B and 4C) . Moreover, consistent with previous studies Balasundaram et al 2006) , all types of nanocrystalline HA agglomerated into micron sizes and hydrothermally prepared nanocrystalline HA agglomerated into smaller sizes than sintered nanocrystalline HA. Specifi cally, hydrothermally treated HA and HA sintered at either 550 °C or at 700 °C had ~1.51, 3.32, and 1.61 μm agglomerated mean particle sizes (Table 1) , respectively. A previous study demonstrated that conventional (or micron) HA agglomerated up to 169 μm (Balasundaram et al 2006) . The signifi cant larger agglomeration sizes of the middle grain sizes nanocrystalline HA may be due to more irregular shapes of HA and possibly greater hydrophobic surface chemistry that increased agglomeration after sintering at 550 °C when compared with the regular rod-like hydrothermal HA. Moreover, Table 1 showed that sintering HA precipitates to either 550 °C or 700 °C achieved higher yield rates of nanocrystalline HA (86.46% and 83.51%) than nanocrystalline HA prepared by hydrothermal treatments (69.54%). The longer HA precipitation time (24 h) before sintering most likely contributed to the higher yield rates of nanocrystalline HA prepared by sintering (whereas only a 10 minute precipitation was used for the hydrothermal treatment).
Characterization of HRN and HA coatings on titanium
SEM images showed that thin layers of different size distributions of nanocrystalline HA in 0.001 mg/ml HRN-K1 were coated on titanium ( Figure 5 ). All of the nanocrystalline HA with HRN coatings exhibited agglomerated nanocrystallites. Uncoated titanium had micron roughness with large grain sizes; specifi cally, small grain sizes of nanocrystalline HA with HRNs revealed dense HA rod crystallite agglomerations ( Figure 5A and 5B). Middle grain sizes of nanocrystalline HA with HRN coatings also showed very dense crystallite agglomerations but irregular crystalline distributions ( Figure 5C and 5D) which was consistent with TEM and Table 1 results. In contrast, large grain sizes of nanocrystalline HA with HRN coatings exhibited the largest HA rod crystallite assemblies with a loose connecting pattern compared with the other coatings ( Figure 5E and 5F ). TEM clearly demonstrated intimate interactions between HRNs and HA when coated on titanium.
Osteoblast adhesion
Results from the cytocompatibility tests provided the fi rst evidence of greater osteoblast adhesion on nanocrystalline HA/HRN coatings on titanium compared with uncoated titanium ( Figure 6 ). Specifi cally, the small and middle grain sizes of nanocrystalline HA/HRN coatings increased osteoblast adhesion by 29.3% and 36.3% on titanium compared with uncoated titanium, respectively. At the same time, the small and middle grain size nanocrystalline HA/HRN coatings also increased osteoblast adhesion more than on the large grain size nanocrystalline HA/HRN coatings. In fact, it has been demonstrated that nanophase materials improved specifi c protein (such as fi bronectin and vitronectin) interactions which contributed to enhanced osteoblast functions on nanophase materials compared with large grain size conventional materials (Webster et al 2000) . For example, Webster and colleagues (2000) showed that there was signifi cantly enhanced osteoblast adhesion on bulk nanophase HA (67 nm Figure 5 SEM micrographs of (A) low magnifi cation and (B) high magnifi caition small grain size nanocrystalline HA (prepared by hydrothermal treatment) with 0.001 mg/ml HRN-K1 coated on titanium; (C) low magnifi cation and (D) high magnifi cation of middle grain size nanocrystalline HA (prepared by sintering at 550 °C) with 0.001 mg/ml HRN-K1 coated on titanium; (E) low magnifi cation and (F) high magnifi caition of large grain size nanocrystalline HA (prepared by sintering at 700 °C) with 0.001 mg/ml HRN-K1 coated on titanium; (G) titanium coated with 0.001 mg/ml HRN-K1 and (H) uncoated titanium. Arrows show the single HA crystallites.
amounts of vitronectin (a protein known to mediate anchorage-dependent cell adhesion [Webster 2001 ]) adsorption. In the present study, a grain size-dependent osteoblast adhesion was also observed for the small and middle grain sizes of nano HA/HRN coatings compared with the large grain size HA/HRN coatings. In addition, osteoblast attachment signifi cantly improved on the 0.001 mg/ml HRN-K1 coated titanium (alone) which is consistent with previous studies (Chun et al 2004 (Chun et al , 2005 . Importantly, although the bone remodeling process in vivo includes various cell types (such as osteoblasts, osteoclasts, and osteocytes) (Webster 2001) , promoting initial osteoblast adhesion on orthopedic implant materials is essential for further new bone growth. Therefore, the signifi cantly enhanced osteoblast adhesion on nanocrystalline HA/HRN coatings observed in this study indicates promise for the continued investigation of these biomimetic coatings for improving orthopedic implants. Clearly, however, future studies will have to evaluate the long-term functions of osteoblasts as well as determine the functions of additional cells necessary for maintaining healthy, strong bones in the body.
As is known, inorganic nanocrystalline HA and elastic collagen (which has helical nanostructures) assemble to form the natural bone matrix (Kaplan et al 1994; Webster 2001) . Thus, much effort has been devoted to apply bioactive and osteoconductive nano HA materials as coatings on implant materials for orthopedic applications (Webster et al 2002; Choi et al 2004; Bigi et al 2005; Sato et al 2005 Sato et al , 2006 Sato et al , 2007 Balasundaram et al 2006; Evis et al 2006; Narayanan et al 2008; Teng et al 2008; Ciobanu et al 2007; Shibli and Mathai 2008) . For instance, recently it has been reported that enhanced cell functions were observed on titanium coated with nano HA by an electrochemical method (Narayanan et al 2008) . However, current HA coatings still can not satisfy patients' high expectations for orthopedic implants due to many shortcomings (ie, lack of rapid osseointegration, low degree of crystallinity, weak interactions with titanium, etc). In this study, it should be emphasized that novel nanotubular HRNs, which are coated with a high degree of nanocrystalline HA on titanium, not only possess fl exible functionalizable chemistries but also have biologically-inspired surface features which may create favorable bone-like environments to improve osseointegration with juxtaposed bone.
For instance, HRNs have potential to serve as a biomimetic template for HA deposition. Figure 7C shows that HA crystals were rapidly formed on HRNs when mixed with CaCl 2 and Na 2 HPO 4 solutions for 2 minutes and were regularly aligned on HRNs in a pattern similar to the HA/collagen pattern in bone. Figure 7D shows randomly agglomerated HA on grids without HRNs. Because the deposition, nucleation and growth of HA crystals in pores of an extracellular collagen matrix are important steps during bone remodeling in vivo, it can be anticipated that the HRN/HA coatings formulated in this study not only mimic the nanostructure of bone but also resemble the HA/collagen self-assembly process to promote natural mineralization (Figure 7 ). In addition, although there were no statistical differences in osteoblast adhesion among the HRNs coated on titanium and nanocrystalline HA/HRN coated on titanium (due to the possibly different concentrations of exposed HRNs on their surfaces), creating a biomimetic coating on titanium is promising to promote osteoblast adhesion and long term bone tissue formation possibly contributing to lower implant failure rates. Importantly, nano HA/HRNs were coated on titanium by adsorption, which was adopted as a model coating method in this study. This coating method could be improved by using commercially available coating techniques (such as the widely used plasma-spray process, sol-gel processing, spin coating, electrospinning, newly developed IonTite TM methods , etc), which may contribute to more surface coverage and coating strength for orthopedic applications.
Lastly, previous studies have demonstrated that HRN-K1 have the potential to increase new bone growth when coated on titanium or hydrogels because of its nanoscale biologically-inspired features and rich lysine moieties (Chun et al 2004; Zhang et al 2008b) . In the current study, the concentration of HRNs that osteoblasts interacted with was below 0.001 mg/ml due to dilution effects of co-coating HRNs and HA (eg, some HRNs may be underneath the HA and not exposed on the surface). Since it has been demonstrated that higher concentrations of HRNs on hydrogels (such as 0.01 mg/ml) can enhance osteoblast adhesion compared with low HRN concentration coatings (Zhang et al 2008b) , it anticipated that increasing HRN concentration on the HA/HRN coating can further augment osteoblast adhesion. Clearly, this should be the focus of further studies.
Conclusions
In summary, different grain sizes of nanocrystalline HA were synthesized in this study and co-coated with a low concentration (specifi cally, 0.001 mg/ml) of HRN-K1 on titanium. The present study demonstrated that HRNs had a high affi nity with nanocrystalline HA. Furthermore, biomimetic nano HA/ HRN coatings offer advantages over traditional orthopedic implant materials (such as uncoated titanium) by enhancing osteoblast adhesion and, thus, deserve further investigation for improving orthopedic applications.
